MediWound (MDWD) Operating Expenses (2013 - 2026)
MediWound (MDWD) posted quarterly Operating Expenses of $6.7 million for Q4 2025, down 4.13% year-over-year from $7.0 million in Q4 2024, and up 16.08% quarter-over-quarter from $5.8 million in Q3 2025.
MediWound (MDWD) Operating Expenses (2013 - 2026) Analysis & Trends
MediWound's Operating Expenses history runs 13 years deep, the most recent figure standing at $6.7 million for Q4 2025.
- In Q4 2025, Operating Expenses fell 4.13% year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $24.2 million (up 16.18% YoY), while the FY2025 annual figure was $28.5 million, up 29.44% from the prior year.
- Operating Expenses for Q4 2025 stood at $6.7 million, up from $5.8 million in the prior quarter.
- The five-year high for Operating Expenses was $7.1 million in Q2 2025, with the low at $3.2 million in Q1 2024.
- The 5-year median for Operating Expenses is $5.1 million (2021), against an average of $5.2 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 34.03% in 2023, then jumped 51.83% in 2024.
- MediWound's Operating Expenses stood at $5.1 million in 2021, then gained by 19.27% to $6.0 million in 2022, then fell by 23.56% to $4.6 million in 2023, then surged by 51.83% to $7.0 million in 2024, then retreated by 4.13% to $6.7 million in 2025.
- Business Quant data shows MDWD's Operating Expenses at $6.7 million in Q4 2025, $5.8 million in Q3 2025, and $7.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 541.02 Mn |
| 10 | MediWound | 169.94 Mn | 138.94 Mn | 337,000.00 | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.80 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 4.67 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 5.76 Mn |
| Jun 30, 2024 | 4.93 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Dec 31, 2023 | 4.61 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 6.04 Mn |
| Sep 30, 2022 | 5.94 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 4.74 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 5.34 Mn |
| Jun 30, 2021 | 5.26 Mn |